BACKGROUND AND PURPOSE: The objective of this study was to determine the relationship between chronic kidney disease (CKD), race-ethnicity, and vascular outcomes. METHODS: A prospective, multiracial cohort of 3298 stroke-free subjects with 6.5 years of mean follow-up time for vascular outcomes (stroke, myocardial infarction, vascular death) was used. Kidney function was estimated using serum creatinine and Cockcroft-Gault formula. Cox proportional hazards models were fitted to evaluate the relationship between kidney function and vascular outcomes. RESULTS: In multivariate analysis, Cockcroft-Gault formula between 15 and 59 mL/min was associated with a significant 43% increased stroke risk in the overall cohort. Blacks with Cockcroft-Gault formula between 15 and 59 mL/min had significantly increased risk of both stroke (hazard ratio, 2.65; 95% CI, 1.47 to 4.77) and combined vascular outcomes (hazard ratio, 1.59; 95% CI, 1.10-2.92). CONCLUSIONS: Chronic kidney disease is a significant risk factor for stroke and combined vascular events, especially in blacks.
BACKGROUND AND PURPOSE: The objective of this study was to determine the relationship between chronic kidney disease (CKD), race-ethnicity, and vascular outcomes. METHODS: A prospective, multiracial cohort of 3298 stroke-free subjects with 6.5 years of mean follow-up time for vascular outcomes (stroke, myocardial infarction, vascular death) was used. Kidney function was estimated using serum creatinine and Cockcroft-Gault formula. Cox proportional hazards models were fitted to evaluate the relationship between kidney function and vascular outcomes. RESULTS: In multivariate analysis, Cockcroft-Gault formula between 15 and 59 mL/min was associated with a significant 43% increased stroke risk in the overall cohort. Blacks with Cockcroft-Gault formula between 15 and 59 mL/min had significantly increased risk of both stroke (hazard ratio, 2.65; 95% CI, 1.47 to 4.77) and combined vascular outcomes (hazard ratio, 1.59; 95% CI, 1.10-2.92). CONCLUSIONS:Chronic kidney disease is a significant risk factor for stroke and combined vascular events, especially in blacks.
Authors: Daniel E Weiner; Hocine Tighiouart; Manish G Amin; Paul C Stark; Bonnie MacLeod; John L Griffith; Deeb N Salem; Andrew S Levey; Mark J Sarnak Journal: J Am Soc Nephrol Date: 2004-05 Impact factor: 10.121
Authors: Carmen A Peralta; Michael G Shlipak; Dongjie Fan; Juan Ordoñez; James P Lash; Glenn M Chertow; Alan S Go Journal: J Am Soc Nephrol Date: 2006-09-07 Impact factor: 10.121
Authors: David T Gilbertson; Jiannong Liu; Jay L Xue; Thomas A Louis; Craig A Solid; James P Ebben; Allan J Collins Journal: J Am Soc Nephrol Date: 2005-11-02 Impact factor: 10.121
Authors: Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey Journal: JAMA Date: 2007-11-07 Impact factor: 56.272
Authors: Guruprasad Manjunath; Hocine Tighiouart; Hassan Ibrahim; Bonnie MacLeod; Deeb N Salem; John L Griffith; Josef Coresh; Andrew S Levey; Mark J Sarnak Journal: J Am Coll Cardiol Date: 2003-01-01 Impact factor: 24.094
Authors: Barry I Hudson; Yeseon Park Moon; Anastasia Z Kalea; Minesh Khatri; Chensy Marquez; Ann Marie Schmidt; Myunghee C Paik; Mitsuhiro Yoshita; Ralph L Sacco; Charles DeCarli; Clinton B Wright; Mitchell S V Elkind Journal: Atherosclerosis Date: 2011-01-21 Impact factor: 5.162
Authors: Adam Davey; Merrill F Elias; Michael A Robbins; Stephen L Seliger; Gregory A Dore Journal: Nephrol Dial Transplant Date: 2012-11-18 Impact factor: 5.992
Authors: Jessica R L Warsch; Tatjana Rundek; Myunghee C Paik; Mitchell S V Elkind; Ralph L Sacco; Clinton B Wright Journal: J Am Geriatr Soc Date: 2013-03-25 Impact factor: 5.562
Authors: Minesh Khatri; Thomas Nickolas; Yeseon P Moon; Myunghee C Paik; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco; Clinton B Wright Journal: J Am Soc Nephrol Date: 2009-09-03 Impact factor: 10.121